Vape regulation in the United States combines youth-use surveillance, product authorization, retailer enforcement, seizures, and state flavor policies. The figures below show measured changes in youth behavior and the scale of regulatory activity, while keeping each statistic tied to its stated year, date, geography, and source.
Contents
- Youth vaping trends
- Flavors, devices, and brands
- FDA authorization and enforcement
- Seizures and illegal-product actions
- Sales changes and market composition
- State flavor restrictions
Youth vaping trends
The strongest national trend in the supplied surveillance figures is a decline in reported youth e-cigarette use. FDA materials from the 2024 National Youth Tobacco Survey (NYTS) put current use among U.S. middle and high school students at 1.63 million in 2024, down from 2.13 million in 2023. The FDA also described the 2024 total as nearly 70% lower than five years earlier.
The 2024 NYTS infographic reported current e-cigarette use among 7.8% of high school students and 3.5% of middle school students. These are percentages for the two school groups, not a combined national percentage. The same 2024 survey materials reported 1.63 million current youth e-cigarette users, which FDA described as about one-third of the more than 5 million youth who reported current e-cigarette use at the 2019 peak.
Youth tobacco use overall also declined. The FDA’s youth tobacco update reported 2.25 million U.S. youth using any tobacco product in 2024, compared with 4.67 million in 2009. FDA described the 2024 level as the lowest youth tobacco-use level in a decade. Because these figures cover any tobacco product, they should not be treated as a second measure of e-cigarette-only use.
| Measure | Earlier figure | Later figure | Source and period |
|---|---|---|---|
| Current youth e-cigarette users | 2.13 million | 1.63 million | FDA NYTS, 2023–2024 |
| Youth current use of any tobacco product | 4.67 million | 2.25 million | FDA youth tobacco update, 2009–2024 |
| Youth current e-cigarette use | More than 5 million | About one-third of that peak | FDA youth e-cigarette release, 2019–2024 |
The FDA’s 2024 youth e-cigarette press release separately characterized the year-over-year change as roughly half a million fewer U.S. youth reporting current e-cigarette use than in 2023. That description is consistent with the two NYTS totals, but the figures should remain labeled as survey estimates rather than a count of every young person who used a device.
The FDA also reported an intervention estimate: its educational efforts prevented nearly 450,000 youth from starting e-cigarette use in one year. The FDA’s evaluation said that viewing its “The Real Cost” advertisements lowered the chance that never-users would later initiate e-cigarette use. This is an evaluation finding about the campaign, not a direct count of observed national prevalence.
Flavors, devices, and brands
Product characteristics remain central to regulation because flavored and disposable products appear prominently in youth-use data. FDA and CDC 2024 NYTS materials, citing the 2023 NYTS, reported that 89.4% of middle and high school students who used e-cigarettes used flavored products. The same release reported that 60.7% used disposable products.
Brand reporting changed across the FDA releases. In 2023, more than 50% of youth who used e-cigarettes reported using Elf Bar products, while more than 20% reported using Esco Bar products, according to the FDA’s May 2024 retailer-warning release. In a December 2024 release, the FDA reported that 5.8% of current youth e-cigarette users reported using Geek Bar products. These percentages come from the specific FDA releases and survey periods stated there; they should not be combined into a single brand ranking.
The national retail-sales evidence also points to a shift in product formats and flavors. In CDC MMWR retail sales data covering January 2020 through December 2022, total e-cigarette unit sales increased 46.6%. Disposable e-cigarettes in fruit, sweet, and other flavors increased after January 2020, while mint and other flavored prefilled-cartridge sales ceased after January 2020. Those are sales-channel observations over the stated period, not estimates of individual use.
FDA authorization and enforcement
The FDA’s authorization figures show a relatively limited authorized product set alongside continuing enforcement. On December 19, 2024, the FDA said it had authorized 34 e-cigarette products and devices. A Truth Initiative market report later cited 39 FDA-authorized e-cigarettes and said all were tobacco- or menthol-flavored. Since the two sources report different dates and totals, each figure should be read within its own measurement point rather than treated as a contradiction-free single series.
On June 21, 2024, the FDA authorized four menthol-flavored e-cigarette products from NJOY through the Premarket Tobacco Product Application pathway. The authorization included two ACE Pod menthol products and two DAILY menthol products. FDA described these as the first non-tobacco flavored e-cigarette products it had authorized.
The FDA also launched its Searchable Tobacco Products Database on March 28, 2024, and said the database would be updated monthly. It groups products into three categories: authorized new tobacco products, pre-existing products, and provisional products removed from review. The database structure is therefore part of the regulatory picture, but the categories do not themselves indicate that every product available for sale is authorized.
Enforcement notices accumulated across 2023 and 2024. As of April 2024, the FDA reported approximately 670 warning letters to firms for manufacturing and/or distributing illegal e-cigarette products, plus more than 550 warning letters to retailers for selling unauthorized e-cigarettes. As of June 16, 2023, the FDA had issued more than 570 warning letters to firms for illegal tobacco products, including e-cigarettes, and had filed civil money penalty complaints against 12 e-cigarette manufacturers.
Specific retail actions included warning letters to more than 180 retailers for illegal Elf Bar and Esco Bars sales during the June 2023 inspection blitz. A nationwide blitz in May 2023 produced warning letters to more than 30 retailers and one distributor for Puff and Hyde products.
Seizures and illegal-product actions
Federal seizures provide another way to measure enforcement scale. On April 30, 2024, the FDA and Department of Justice seized more than 45,000 unauthorized e-cigarettes valued at more than $700,000. On June 27, 2024, the FDA and Customs and Border Protection seized 53,700 unauthorized e-cigarette products valued at more than $1.08 million.
The largest supplied seizure figure came on October 22, 2024, when the FDA and CBP seized approximately 3 million unauthorized e-cigarette products with an estimated retail value of $76 million. The word “estimated” matters here: the retail value is an estimate, while the product count is reported as approximately 3 million.
The FDA’s warning-letter activity also continued through late 2024. On May 1, 2024, it issued warning letters to 14 online retailers for unauthorized e-cigarettes. On December 5, 2024, it issued warning letters to 115 brick-and-mortar retailers. On December 19, 2024, it issued warning letters to eight online retailers and one manufacturer concerning flavored disposable e-cigarettes.
The FDA described a task force formed with the Department of Justice in 2024 to curb illegal e-cigarettes. Its year-in-review framing said enforcement operations were increasing in frequency to address unauthorized products. These statements describe enforcement activity and agency strategy; they do not quantify the share of all unauthorized products removed from commerce.
Sales changes and market composition
Later market analyses help show why authorization counts and enforcement actions matter. A Truth Initiative retail market analysis reported that FDA-authorized e-cigarettes accounted for 13.7% of the e-cigarette market, while illegal e-cigarette products accounted for 86.3%. The same analysis said the 34 FDA-authorized e-cigarette products represented the full set of authorized products used in its market-share calculation.
The reported market split is specific to that analysis and its product definition. It should not be presented as a universal estimate for every channel, date, or geography. Its value is that it describes the relationship between the authorized product set and the broader retail market in the cited analysis.
The same Truth Initiative market reporting said the total amount of nicotine sold in e-cigarettes surged 249.2% between February 2020 and June 2024. In related reporting, oral nicotine pouch nicotine sales reached 3,407 kilograms by March 2024, while disposable e-cigarette nicotine sales reached 3,123 kilograms by March 2024. These are nicotine-sales measures, not user counts, and the pouch figure concerns a different product category from e-cigarettes.
Together, the sales figures show why unit sales, nicotine quantity, and youth prevalence should not be substituted for one another. A change in units can reflect product format, concentration, or purchasing patterns, while a survey percentage measures reported use within a defined student population.
State flavor restrictions
State and local policies add a separate layer to federal authorization and enforcement. The Truth Initiative flavored-tobacco policy map reported that 27.52% of the U.S. population lived in a jurisdiction with a flavored-tobacco sales restriction in effect as of September 30, 2024. The same map said 14 states had at least one jurisdiction with such a restriction on that date.
California provides one of the clearest supplied before-and-after sales examples. A CDC Foundation monitoring brief reported that monthly e-cigarette sales in California declined 41% after statewide flavor restrictions took effect. In related CDC Foundation monitoring work, statewide restrictions on non-tobacco flavored e-cigarettes were associated with total unit-sales reductions of 25% to 31%, depending on the state.
A California evaluation covering January 2023 through June 2024 reported that the state’s flavored-tobacco ban led to a 37% decrease in average quarterly nicotine milligrams sold per capita for e-cigarettes. The same evaluation reported a 10.6% decline in per-capita cigarette packs sold in California retail outlets. Both are California retail measures over the stated period, and neither should be generalized automatically to every state or product category.
These policy statistics describe associations and observed changes around restrictions. They do not, by themselves, establish that every change was caused only by a flavor policy. For readers tracking smoke-free living, the practical distinction is important: national youth-use estimates, federal enforcement totals, retail sales, nicotine quantities, and state policy evaluations answer different questions and should be compared only with their measurement definitions intact.